Pharmaceutical policies in Finland – Challenges and opportunities
Elias Mossialos and Divya Srivastava
Prepared at the request of the Health Department, Ministry of Social
Affairs and Health, Finland
World Health Organization 2008, on behalf of the European Observatory on
Health Systems and Policies
Available online as PDF file at:
http://www.euro.who.int/Document/E91239.pdf
“….Finland, like many other countries with well-developed health systems,
has struggled with its pharmaceutical policy on issues such as needs-based
universal access, cost–effectiveness (CE) and affordability of its growing
drug budget. Incremental policy changes have been followed by some fairly
drastic measures to control growth in pharmaceutical expenditure. There
has been considerable public debate on pharmaceutical issues and the need
for a more predictable overall strategy in this policy field…..”
Content:
Executive summary
Chapter 1: Introduction
Chapter 2: Overview of the pharmaceutical system in Finland
Chapter 3: Trends in pharmaceutical expenditure and consumption
Chapter 4: Supply-side policies concerning pharmaceuticals
Chapter 5: How to influence providers
Chapter 6: Evaluation of options and recommendations
Annex 1: Background information on the review of pharmaceutical policy
prepared by the Ministry of Social Affairs and Health
Annex 2: Stakeholders consulted
References
Atencion Primaria 